{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:06:30Z","timestamp":1793052390220,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.actatropica.2018.06.016","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T14:56:32Z","timestamp":1529420192000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone"],"prefix":"10.1016","volume":"185","author":[{"given":"Samuel J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitta R.Y.","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foday","family":"Sahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-9482","authenticated-orcid":false,"given":"Mohamed","family":"Samai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha S.","family":"Swaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-4495","authenticated-orcid":false,"given":"Didier","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-977X","authenticated-orcid":false,"given":"Marian","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2018.06.016_bib0005","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4269\/ajtmh.15-0826","article-title":"Efficacy of artesunate\/amodiaquine in the treatment of uncomplicated malaria among children in Ghana","volume":"97","author":"Abuaku","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0020","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/AAC.00610-09","article-title":"Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility","volume":"53","author":"Andriantsoanirina","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Tracking resistance to artemisinin collaboration (T.R.A.C) spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1475-2875-12-405","article-title":"An innovative tool for moving malaria PCR detection of parasite reservoir into the field","volume":"12","author":"Canier","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0040","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/tmi.12595","article-title":"Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis","volume":"20","author":"Chico","year":"2015","journal-title":"Trop. Med. Int. Health"},{"issue":"455","key":"10.1016\/j.actatropica.2018.06.016_bib0045","article-title":"In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo","volume":"15","author":"de Wit","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12936-016-1381-8","article-title":"Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013","volume":"15","author":"Dorkenoo","year":"2016","journal-title":"Malar. J."},{"issue":"October (9700)","key":"10.1016\/j.actatropica.2018.06.016_bib0055","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(09)60997-1","article-title":"Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Gosling","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3201\/eid2401.170864","article-title":"Drug-resistant polymorphisms and copy numbers in Plasmodium falciparum, Mozambique, 2015","volume":"24","author":"Gupta","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","article-title":"The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine\u2013pyrimethamine preventive therapy in Malawian pregnant women","volume":"211","author":"Gutman","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria","volume":"185","author":"Kublin","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0080","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/AAC.00835-15","article-title":"Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment","volume":"59","author":"Leang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0085","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"Menard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0090","series-title":"Strategic Plan 2009-2015","author":"Ministry of Health","year":"2009"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0095","series-title":"Sierra Leone Malaria Control Strategic Plan 2016-2020","author":"Ministry of Health","year":"2015"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0100","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3201\/eid1909.130133","article-title":"Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania","volume":"19","author":"Minja","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"123","key":"10.1016\/j.actatropica.2018.06.016_bib0105","article-title":"High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children","volume":"10","author":"Mombo-Ngoma","year":"2011","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.actatropica.2018.06.016_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154618","article-title":"Therapeutic efficacy of artemether-lumefantrine (Coartem\u00ae) in treating uncomplicated P. falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study","volume":"11","author":"Nega","year":"2016","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.actatropica.2018.06.016_bib0115","article-title":"Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin","volume":"15","author":"Ogouy\u00e8mi-Hounto","year":"2016","journal-title":"Malar. J."},{"issue":"33","key":"10.1016\/j.actatropica.2018.06.016_bib0120","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study","volume":"13","author":"Ogutu","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0125","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","article-title":"Mapping sulphadoxinepyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa","volume":"7","author":"Okell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0035-9203(01)90250-0","article-title":"Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?","volume":"95","author":"Omar","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12936-016-1281-y","article-title":"In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014","volume":"15","author":"Paczkowski","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3201\/eid2304.161872","article-title":"Treatment failure of dihydroartemisinin\/piperaquine for Plasmodium falciparum malaria, Vietnam","volume":"23","author":"Phuc","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"62","key":"10.1016\/j.actatropica.2018.06.016_bib0145","article-title":"Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015","volume":"16","author":"Plucinski","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.04181-14","article-title":"Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and U\u00edge Provinces, Angola","volume":"59","author":"Plucinski","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0155","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(03)12951-0","article-title":"Antifolate antimalarial resistance in southeast Africa: a population-based analysis","volume":"361","author":"Roper","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12936-017-1831-y","article-title":"Increase in the prevalence of mutations associated with sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso","volume":"16","author":"Ruizendaal","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0165","first-page":"4","article-title":"Assessment of the therapeutic efficacy of two artemisinin-based combinations in the treatment of uncomplicated falciparum malaria among children under 5 years in four district hospitals in Sierra Leone","volume":"5","author":"Sahr","year":"2013","journal-title":"Sierra Leone J. Biomed. Res."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0170","first-page":"45","article-title":"Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine","volume":"26","author":"Sow","year":"2016","journal-title":"Med. Sante Trop."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-3156.2004.01239.x","article-title":"Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda","volume":"9","author":"Staedke","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"27","key":"10.1016\/j.actatropica.2018.06.016_bib0190","article-title":"Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam","volume":"16","author":"Thanh","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker","volume":"15","author":"Tun","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0200","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in children aged less than 15 years in Guinea-Bissau - an open-label non-inferiority randomised clinical trial","volume":"1","author":"Ursing","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0205","series-title":"Methods for Surveillance of Antimalarial Drug Efficacy","author":"WHO","year":"2009"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0210","series-title":"WHO Policy Recommendation on Intermittent Preventive Treatment During Infancy with Sulphadoxine-Pyrimethamine (SP-IPTi) for Plasmodium falciparum Malaria Control in Africa","author":"WHO","year":"2010"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0215","series-title":"Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000\u20132010","author":"WHO","year":"2010"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0220","series-title":"Defining and Validating a Measure of Parasite Resistance to Sulfadoxine-Pyrimethamine (SP) That Would Be Indicative of the Protective Efficacy of SP for Intermittent Preventive Treatment in Infancy (IPTi-SP)","author":"WHO","year":"2010"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0225","series-title":"WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP)","author":"WHO","year":"2014"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0230","series-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2015"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0235","series-title":"Status Report on Artemisinin and ACT Resistance (April 2017)","author":"WHO","year":"2017"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0240","series-title":"World Malaria Report 2016","author":"WHO","year":"2017"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0245","series-title":"Management of severe malaria \u2013 a practical handbook","author":"WHO","year":"2013"},{"key":"10.1016\/j.actatropica.2018.06.016_bib0250","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.06.016_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113311","article-title":"Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children","volume":"9","author":"Yeka","year":"2014","journal-title":"PLoS One"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18301384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18301384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:16:34Z","timestamp":1757549794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X18301384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"alternative-id":["S0001706X18301384"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.06.016","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}